Photo Flash: Honey LaBronx Hosts 'PrEP-O-Licious!'
Today, the FDA has approved the use of a medication which prevents the risk of HIV transmission by up to 99%. Truvada (Gilead Sciences, Inc) was approved by the FDA for the treatment of HIV in August of 2004 and was extended for Pre-Exposure Prophylaxis (PrEP) for prevention of HIV in July of 2012. In association with Damon L. Jacobs (psychotherapist, author), Gary Weingarten (Verlaine Bar and Lounge), and other organizations, Honey LaBronx hosted the first party in New York to spread the word about this game changing prevention strategy. Scroll down for photos!